COVID-19: Preventive Measures in Multiple Sclerosis Patients and Others on Immuno-Modulators
We know things are changing fast. This page sets out what we know about treatments right now. We’re keeping it...
Category: Multiple sclerosis
Multiple Sclerosis Neurobiology and Therapeutic Strategies
Multiple sclerosis (MS) is an autoimmune, acquired T cell-mediated neuro-inflammatory disorder that is marked by axonal degeneration and focal demyelination...
Role of Microglia in Multiple Sclerosis
Glial cells play many critical roles in the mediation of immune responses, transmission of axon potentials and maintenance of CNS...
Fewer Postpartum MS Relapses During Breastfeeding
NEW YORK (Reuters Health) – Breastfeeding appears to protect against postpartum multiple sclerosis (MS) relapses, according to a fresh look...
FDA Okays First Generics for MS Drug Fingolimod (Gilenya)
The US Food and Drug Administration (FDA) has approved three applications for first generic versions of fingolimod capsules (Gilenya, Novartis)...
From Flame to Inflammation: How Smoking Likely Worsens MS
Inflammation could be a key mechanism behind the well-accepted adverse associations between cigarette smoking and multiple sclerosis (MS), a new...
Multiple sclerosis – Treatment
There is no cure for multiple sclerosis. Treatment typically focuses on speeding recovery from attacks, slowing the progression of the...
Multiple sclerosis – Diagnosis
Diagnosis Neurological exam There are no specific tests for MS. Instead, a diagnosis of multiple sclerosis often relies on ruling out...
Multiple sclerosis – II. nd. chapter
Causes The cause of multiple sclerosis is unknown. It’s considered an autoimmune disease in which the body’s immune system attacks...
Multiple sclerosis – I.st. chapter
Overview Multiple sclerosis Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system)....
